Netherlands· NL-d34902f7a6f6

Ciclesonide Sandoz Inhalator 80 microgram/dosis, aërosol, oplossing

A ciclesonide product containing ciclesonide, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 15 of our 19 countries.

ATC R03BA08

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ciclesonideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ciclesonide is registered in 15 of 19 countries.

Countries holding a registration under ATC R03BA08 (ciclesonide), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search ciclesonide products by name

Ciclesonide · ATC R03BA08

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: CICLESONIDE
Manufacturer: Sandoz B.V.
Country: Netherlands (NL)
ATC code: R03BA08
ATC class: Ciclesonide
Defined daily dose: 0.16 mg, Inhal
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
130307

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

77 interactions on record for ciclesonide.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ciclesonide against other medicines How interaction checks work

Ciclesonide · interactions on record

77 records

5 severe
42 moderate
19 minor
11 info

Most severe, free to view

DesmopressinH01BA02severe
CladribineL01BB04severe
Dinutuximab betaL01FX06severe
Brexucabtagene autoleucelL01XL06severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ciclesonide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ciclesonide products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

Austria · Alvesco, Ciclesonid Genetic
Bulgaria · Alvesco, Алвеско
Cyprus · Alvesco
Czechia · Alvesco, Ciclesonide Glenmark
Germany · Alvesco, Ciclesonid Glenmark
Denmark · Alvesco, Ciclasonide Glenmark
Spain · Alvesco
Finland · Alvesco, Ciclesonide Glenmark
France · Alvesco
United Kingdom (Northern Ireland) · Alvesco, Ciclesonide Advanz Pharma
Greece · Alvesco, Ciclair
Croatia · Airclesio, Alvesco
Hungary · Alvesco, Ciclesonid Sandoz
Ireland · Alvesco
Italy · Airven, Alvesco
Latvia · Alvesco
Norway · Alvesco, Ciclesonide Glenmark
Poland · Alvesco, Cyxezon
Romania · Alvesco Inhaler
Sweden · Alvesco, Ciclesonide Glenmark
Slovenia · Alvesco, Cmykle
Slovakia · Airclesio, Alvesco

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e9ef8825-e4b6-4dc1-9844-17e5d191edde
GET /v1/drugs/e9ef8825-e4b6-4dc1-9844-17e5d191edde?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Aërosol, oplossing",
  "route": "Inhalatie",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h130307_smpc.pdf",
  "strength": null,
  "atc_label": "Ciclesonide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130307",
  "excipients": [
    "ETHANOL",
    "NORFLURAAN"
  ],
  "substances": [
    "CICLESONIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130307.pdf",
  "authorised_at": "2024/02/22",
  "procedure_number": "NL/H/5651/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "130307",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about ciclesonide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console